Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00017459

Public ClinicalTrials.gov record NCT00017459. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 1:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The International Tirazone Triple Trial (i3T): A Phase III, Randomized Efficacy And Safety Study Of The Combination Chemotherapy With Tirapazamine+Cisplatin+Vinorelbine Versus Cisplatin+Vinorelbine In Subjects With Inoperable, Previously Untreated, Non-Small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if cisplatin and vinorelbine are more effective with or without tirapazamine in treating non-small cell lung cancer PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin plus vinorelbine with or without tirapazamine in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Study identification

NCT ID
NCT00017459
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2000 (Type not available)
Primary completion
Not listed
Completion
Feb 2004 (Actual)
Last update posted
Aug 2, 2013

2000 – 2004

United States locations

U.S. sites
42
U.S. states
17
U.S. cities
38
Facility City State ZIP Site status
Tower Hematology Oncology Medical Group Los Angeles California 90048 —
Medical Oncology Internal Medicine Los Angeles California 90067 —
Bay Area Tumor Institute Oakland California 94609 —
Medical Oncology Care Associates Orange California 92668 —
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128 —
John Wayne Cancer Institute Santa Monica California 90404 —
Los Angeles County Harbor-UCLA Medical Center Torrance California 90509 —
Medical Oncology-Hematology Consultants, P.A. Wilmington Delaware 19808 —
Washington Cancer Institute Washington D.C. District of Columbia 20010 —
Veterans Affairs Medical Center - Washington, DC Washington D.C. District of Columbia 20422 —
University of Florida Health Science Center - Jacksonville Jacksonville Florida 32209 —
Watson Clinic Lakeland Florida 33804-5000 —
Ocala Research Institute, Inc Ocala Florida 34471 —
Ocala Oncology Center Ocala Florida 34474 —
Saint Alphonsus Regional Medical Center Boise Idaho 83706 —
Dreyer Medical Clinic Aurora Illinois 60506 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Northwest Oncology and Hematology, S.C. Elk Grove Village Illinois 60007 —
Rockford Clinic Rockford Illinois 61103 —
Cancer Care Center New Albany Indiana 47150 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Hematology-Oncology Clinic Baton Rouge Louisiana 70808 —
University of Minnesota Cancer Center Minneapolis Minnesota 55455 —
Capitol Comprehensive Cancer Care Clinic Jefferson City Missouri 65109 —
Veterans Affairs Medical Center - Kansas City Kansas City Missouri 64128 —
St. John's Mercy Medical Center St Louis Missouri 63141 —
Western Montana Clinic Missoula Montana 59803 —
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095 —
Brookdale University Hospital and Medical Center Brooklyn New York 11212 —
Interlakes Oncology/Hematology PC Rochester New York 14623 —
New York Medical College Valhalla New York 10595 —
Akron General Medical Center Akron Ohio 44302 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
North Penn Hospital Lansdale Pennsylvania 19446-1200 —
Fox Chase - Temple Cancer Center Philadelphia Pennsylvania 19140 —
Lone Star Oncology Austin Texas 78759 —
Center for Oncology Research and Treatment, Medical City Hospital Dallas Texas 75230 —
Southwest Cancer Center at University Medical Center Lubbock Texas 79415 —
Baptist Health System Cancer Program San Antonio Texas 78205 —
Cancer Therapy Research Center San Antonio Texas 78229 —
Veterans Affairs Medical Center - Temple Temple Texas 76504 —
Arlington-Fairfax Hematology/Oncology, PC Arlington Virginia 22205 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00017459, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2013 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00017459 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →